The One Job a Microdosing Journal Can Actually Do Well
Search "microdosing journal best practices" and you'll find the same template everywhere: date, dose, intention, mood score, three lines on creativity, a weekly reflection prompt. Almost none of it would be any use to a doctor. That matters, because Amanita muscaria is showing up in emergency departments — the FDA's September 2024 scientific memorandum reported that a National Poison Data System search for muscimol- and ibotenic-acid-containing mushrooms returned 695 cases in the first six months of 2024 alone, with hospitalisation, intubation and critical care among the documented outcomes (FDA Scientific Memorandum on Amanita muscaria, 2024). A journal can't tell you whether a dose worked. It can tell a clinician what you took, when, and what else was on board.
This article is about that second document. The case against the first one we made separately, in why your Amanita microdosing journal can't tell you what you think it can. The question here is narrower: given that a journal can't establish cause and effect, what should it contain, and who is it for?
What Poison Control Asks For — and What Your Template Left Out
There's an easy way to find out which fields matter: look at what poison specialists ask for. America's Poison Centers lists the information you should have ready when you call 1-800-222-1222 — the exact product name as printed on the label, the amount involved, the time of exposure, the route by which it contacted the person, the patient's age and weight, and their health history including current medications (Poison Control, poison.org). They also tell you to bring the container.
Now compare that against a typical microdosing journal. Dose is usually there, though often as "my usual" rather than a number. Time is sometimes there. Product name, form, and source are frequently missing entirely. Concurrent medications are almost never recorded. Weight is nobody's idea of a journaling prompt. The overlap between the two lists is roughly one and a half fields out of six — which means that at the exact moment a journal would be worth the most, it answers almost none of the questions being asked.
That's the reframe worth making. Your entry's highest-value reader isn't you, later. It's someone triaging you — and they need boring, specific, verifiable facts.
Why the Timestamp Outranks the Mood Rating
Amanita muscaria's clinical course is not a single event you can summarise at bedtime. In two severe cases reported by Meisel and colleagues, a 75-year-old man vomited 30 minutes after eating one large foraged cap, presented with stable vital signs, then deteriorated five hours later — Glasgow Coma Score 8, blood pressure 70/50, heart rate 45 — needing intubation and atropine before a full recovery. The second patient, a 44-year-old who had taken 4 to 5 dried caps, arrived after cardiopulmonary arrest roughly ten hours post-ingestion and died nine days later (Meisel et al., Wilderness & Environmental Medicine, 2022). In a separate series of 34 regional poison-centre cases, all but one patient developed symptoms within six hours — a window that spans most of a working day.
Five hours. Ten hours. Those gaps are the whole argument for a timestamped log rather than a daily summary. "Felt fine" written at 9pm collapses an entire evening into two words and erases the one number a clinician would want most: when did it actually go in? Note the ingestion time to the minute, and note the clock time of anything you notice afterwards, even when what you noticed was nothing. A record of no effect at 90 minutes is real information if something happens at hour five.
"Mushroom" Is Not a Product Name
Write "took my Amanita" and you've recorded almost nothing, because the entry doesn't identify a species, a form, or a supplier. Species alone changes the clinical picture substantially. A regional poison centre review of 34 muscimol and ibotenic acid exposures over 2002–2016 found Amanita pantherina ingestions markedly more symptomatic than A. muscaria — GI symptoms in 80% versus 35%, CNS depression in 70% versus 35%, CNS excitation in 70% versus 35%, with five patients intubated across the series (Moss & Hendrickson, Clinical Toxicology, 2019). Two closely related mushrooms, two different risk profiles, one word in your journal.
Product form deserves the same precision, and so does the brand — because what's on the label isn't always what's in the package. A CDC field report from Charlottesville, Virginia described five people who required hospital evaluation after eating gummies labelled as containing A. muscaria; when five brands of these "nootropic" gummies were analysed, three contained undisclosed psilocybin and psilocin, Schedule I substances that appeared nowhere on the label (CDC, MMWR, July 2024). "Amanita gummy, 1" would have been a factually false entry — through no fault of the person writing it.
So: record the species as printed, the form (dried cap, powder, capsule, tincture), the brand and supplier, and photograph the packaging. Whole, intact dried caps at least let a mycologist or clinician confirm what they're looking at afterwards. A powder or a gummy does not.
Same Product, Different Batch: Your Log Is the Only Continuity
Even when species and supplier are stable, the chemistry isn't. Japanese forensic scientists measuring Amanita caps by GC/MS found ibotenic acid ranging from under 10 ppm to 2,845 ppm, and muscimol from 46 to 1,052 ppm, across A. muscaria samples (Tsujikawa et al., Forensic Science International, 2006). That's more than a twentyfold spread in muscimol inside a single species. A broader 2023 Toxicon survey of 84 samples across 24 Amanita species widened it further, reporting ibotenic acid from 0.61 to 32.09 g/kg dry weight (Toxicon, 2023, PMID 37611670).
A gram, in other words, is a unit of weight rather than a unit of dose — we cover why that gap can't be closed at home in what lab analysis actually shows about potency and why preparation is a sampling problem, not a recipe. The journalling consequence is simple: log the lot, and start a new section whenever the batch changes. Otherwise an unexplained strong reaction in month four has no candidate explanation, because the one variable that plausibly changed is the one you never wrote down.
The Line Almost Nobody Writes Down
What else was in your system? Alcohol, prescribed sedatives, sleep aids, antihistamines, anything else taken that day — this is the field that gets skipped most often and matters most in an emergency. Muscimol is a GABA-A agonist, so it acts on the same inhibitory system as alcohol, benzodiazepines and Z-drugs, and the additive risk is depression of consciousness and breathing.
There's a specific reason a clinician needs to know. Meisel and colleagues note that because Amanita's CNS toxicity typically moves from an excitation phase into a depression phase, patients are already at high risk of profound CNS depression, and they describe an association between benzodiazepine administration and the subsequent need for intubation. Benzodiazepines remain the treatment of choice for seizures — but a treating physician weighing that decision is better off knowing you'd already had two drinks and a sleeping tablet. Your journal is where that fact lives, or doesn't.
Record the substance, the dose, and the time, in the same entry. Not in a separate app. Not from memory afterwards.
Your Entry May Be the Only Record That Reaches Anyone
Adverse events involving supplements are drastically under-reported. An FDA-commissioned analysis estimated that the agency is notified of fewer than 1% of adverse events associated with dietary supplements, and a review of the FDA's CAERS database for 2004–2013 put the reporting rate at roughly 2% (Timbo et al., Annals of Pharmacotherapy, 2018). Only 20% of the reports that do reach the FDA come from health professionals (HHS Office of Inspector General).
So the captured numbers look small — the 2023 National Poison Data System report logged 136 ibotenic acid and muscimol mushroom exposures, 44 moderate and 7 major outcomes (Medscape, Hallucinogenic Mushroom Toxicity) — partly because most events never get reported at all. A timestamped entry is what makes a report possible weeks later, once the details have gone. In the US you can file one through the FDA Safety Reporting Portal or MedWatch Form 3500B; a poison centre call is free and confidential.
A Minimum Viable Entry — and What It Still Can't Do
Strip away the reflection prompts and a genuinely useful entry is about a dozen fields, most of which take seconds:
- Date and clock time of ingestion, to the minute
- Species exactly as printed on the label
- Product form — dried cap, powder, capsule, tincture
- Brand, supplier, and lot or batch number (photograph the packaging)
- Amount by weight or volume, measured rather than estimated
- Preparation method, if you prepared it yourself
- Everything else taken that day: medications, alcohol, supplements, with times
- Your current weight and any relevant health conditions, on the first page rather than in every entry
- Timestamped observations — including explicit notes of nothing happening
- Any GI, cardiovascular, or consciousness-level symptom, with its time
- Whether anyone else was present
- Whether the batch changed since the last entry
Notice what isn't on that list: mood scores, creativity ratings, intention statements. Keep them if you like them — they cost nothing. Just don't mistake them for data. Unblinded self-report tracks what you believed you took more closely than what you actually took, which is the finding behind our companion piece on self-blinding. This record isn't designed to prove an effect. It's designed to be useful to somebody else, quickly, on a bad day.
Frequently Asked Questions
What should a microdosing journal record that most templates leave out?
The fields poison specialists ask for: exact product name as labelled, amount, time of exposure, route, patient age and weight, and current medications (Poison Control). Most templates capture dose and mood but omit product identity, batch, and concurrent medications — the three that matter most clinically.
Why does the exact ingestion time matter so much?
Because deterioration can be delayed. In one documented case a patient was stable on presentation and then declined sharply five hours after ingestion; in another, cardiopulmonary arrest occurred roughly ten hours after eating 4–5 dried caps (Meisel et al., 2022). A daily summary erases the timeline a clinician needs.
Is writing down the brand and batch number really necessary?
Yes, for two reasons. Muscimol content varied from 46 to 1,052 ppm across A. muscaria samples in one forensic analysis, so batches genuinely differ. And CDC investigators found three of five brands of Amanita-labelled gummies contained undisclosed psilocybin and psilocin, meaning the label alone may not describe what you took.
Should I record alcohol and prescription medications in the same entry?
Yes. Muscimol acts on GABA-A receptors, the same inhibitory system as alcohol and benzodiazepines, so combinations raise the risk of respiratory and CNS depression. Clinicians also weigh benzodiazepine treatment carefully in these presentations, and knowing what you'd already taken changes that calculation.
Can a journal tell me whether microdosing is working for me?
No, not on its own. Self-report without blinding reflects expectation as much as pharmacology, which is a structural limit rather than a discipline problem. Amanita muscaria is not a proven treatment for anxiety, sleep problems, ADHD, or any diagnosed condition — a journal cannot substitute for a clinical assessment.
Where do I report an adverse reaction, and does it matter if I do?
In the US, call a poison centre on 1-800-222-1222 for anything acute, and file non-urgent reports through the FDA Safety Reporting Portal or MedWatch Form 3500B. It matters because reporting rates are estimated at roughly 1–2% of actual supplement-associated adverse events (Timbo et al., 2018), so surveillance data badly understates real-world experience.
Bottom Line
Most journaling advice for microdosing is built around a question a notebook can't answer — did it work? — and skips the one it can. The valuable fields are the unglamorous ones: exact time of ingestion, species and form as labelled, brand and batch, measured amount, everything else in your system, and timestamped observations including the absence of effects. That's almost exactly the list poison specialists ask for, and Amanita's clinical course can turn hours after a stable start. Keep the mood notes if they mean something to you. Just build the entry around the parts a stranger could use.
Amanita muscaria is not a proven treatment for anxiety, sleep problems, ADHD, or any diagnosed condition; anyone considering it for those reasons should speak with a healthcare professional. Always research local regulations before purchase. This article is informational and is not medical advice.
About the author: Viktor writes about mushroom chemistry, sourcing, and safety for Amanita Store, with a focus on what published analytical data actually supports.